Matria, its directors and certain of its executive officers, as well as Inverness, its directors and certain of its executive officers, may be considered participants in the solicitation of proxies in connection with the proposed transaction. Information about the directors and executive officers of Matria and their respective interests in the proposed transactions will be set forth or incorporated by reference in the proxy statement/prospectus that Inverness and Matria will file with the SEC in connection with the proposed transaction. Information about the directors and executive officers of Matria is available in Matria's proxy statement for its 2007 annual meeting of stockholders, as filed with the SEC on April 30, 2007 and in its annual report on Form 10-K, as filed with the SEC on March 20, 2007. Investors may obtain additional information regarding the interests of such participants by reading the proxy statement/prospectus when it becomes available.
This communication shall not constitute an offer to sell nor the solicitation of an offer to buy any securities.
Cautionary Note Regarding Forward-Looking Statements
This press release may contain forward-looking statements within the
meaning of the federal securities laws, including statements regarding
potential synergies and benefits of the proposed business combination.
These statements reflect the parties
'/>"/>
| SOURCE Inverness Medical Innovations Copyright©2008 PR Newswire. All rights reserved |